Moderna

The company hopes to earn the trust of the public and of scientists who have clamored for details of its study.Moderna Therapeutics’s headquarters in Cambridge, Mass.Credit...Tony Luong for The New York TimesSept. 17, 2020Updated 10:22 a.m. ETThe biotech company Moderna released a 135-page document on Thursday that spells out the details of how it is…

Moderna is charging between $32 to $37 per dose for its coronavirus vaccine for some customers, under cheaper "pandemic pricing," it said Wednesday.The Cambridge, Massachusetts-based company is currently in discussion for larger volume agreements that will have a lower price, Moderna CEO Stephane Bancel said on a conference call discussing the company's second-quarter financial results. "We are…

By Carl O'DonnellJuly 27 (Reuters) - Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday.The trials, both announced on Monday, are the first late-stage studies supported by the Trump administration's…

This biotech company is hard at work to win the coronavirus vaccine race. Will it succeed? All eyes are on the drug manufacturers that are racing to develop the first safe and efficacious coronavirus vaccine. Global COVID-19 cases have crossed the 15 million mark, with at least 634,000 deaths worldwide. In the United States alone,…

From San Diego to St. Louis to Savannah, researchers are gearing up for Moderna’s 30,000-person COVID-19 vaccine trial, set to begin Monday.Many hope that a safe and effective vaccine will control the spread of the worst pandemic in a century and bring life back to some semblance of normalcy. More than 15 million people have…